USA: A recent study, published in JAMA Network Open as a research letter, highlights a significant link between anti-obesity ...

Researchers at Henry Ford Health, collaborating with WeightWatchers International, report that more than 40% of individuals ...

A collection of common and new medications is showing good results against the constellation of symptoms that individualize ...

Nearly half of individuals consuming alcohol at baseline reduced their alcohol consumption following the initiation of AOMs.

University of Wisconsin–Madison biochemists have developed a new, efficient method that may give first responders, ...

A study of 14,000 WeightWatchers participants is the latest to suggest that Ozempic and similar obesity drugs could be ...

University of Wisconsin–Madison biochemists have developed a new, efficient method that may give first responders, ...

A study using Swedish patient data found anti-obesity drugs were linked with fewer hospitalizations related to alcohol use, ...

Differences emerged as to which participants were more likely to cut back on drinking after starting medication. For example, ...

This cohort study among individuals participating in a weight loss program found that nearly half of those consuming alcohol at baseline decreased their alcohol use after anti-obesity medication ...

This medication, sold under the name Contrave, is an oral medication that combines bupropion, an antidepressant, and naltrexone, which is used to manage opioid or alcohol use disorder. A doctor ...

After hours: November 27 at 6:48 PM EST Loading Chart for SCLX ...